Clinical Study on the Distribution Characteristics of Pathogens and Risk Factors for Urinary Tract Infections in Patients with Type 2 Diabetes Mellitus
Objective: To clarify the distribution pattern of pathogens causing urinary tract infections (UTIs) in patients with type 2 diabetes mellitus (T2DM) and analyze the risk factors influencing the occurrence of infection, providing evidence-based guidance for precise clinical prevention and treatment. Methods: Clinical data from 191 patients with T2DM admitted to Guangxi-ASEAN Economic and Technological Development Zone People’s Hospital (The Tenth People’s Hospital of Nanning) from January 2024 to December 2025 were retrospectively collected. Patients were divided into an infection group (48 cases) and a non-infection group (143 cases) based on urine culture results. A microbial identification system was used to identify pathogens and perform drug susceptibility testing in the infection group. Differences in gender, age, glycated hemoglobin (HbA1c), and renal function-related indicators (creatinine, uric acid, urea, etc.) were compared between the two groups. Multivariate logistic regression analysis was used to identify independent risk factors for UTI. Results: The incidence of UTI among the 191 patients was 25.13% (48/191). A total of 50 pathogen strains were isolated from the infection group, including 38 strains (76.00%) of Gram-negative bacteria, predominantly Escherichiacoli (29 strains, 58.00%); 7 strains (14.00%) of Gram-positive bacteria; and 5 strains (10.00%) of fungi. Drug susceptibility results showed that E. coli had high resistance rates to ampicillin and cefazolin but good sensitivity to imipenem and meropenem. Univariate analysis showed that levels of HbA1c, creatinine, and urea were significantly higher in the infection group than in the non-infection group (P < 0.05), while the endogenous creatinine clearance rate was significantly lower (P < 0.05). Multivariate logistic regression analysis indicated that HbA1c > 6.0% (OR = 3.862, 95% CI: 1.985 - 7.513, P < 0.001) and creatinine > 104.0 μmol/L (OR = 2.945, 95% CI: 1.528 - 5.678, P = 0.001) were independent risk factors for UTI in T2DM patients. Conclusion: The primary pathogen causing UTIs in T2DM patients is E. coli. Poor glycemic control and renal function impairment are key risk factors for infection. Clinically, monitoring and intervention for such high-risk patients should be strengthened, and antimicrobial agents should be selected rationally to improve prognosis.
References
[1]
American Diabetes Association Professional Practice Committee for Diabetes (2026) Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2026. Diabetes Care, 49, S61-S88.
[2]
Saliba, W., Nitzan, O., Chazan, B. and Elias, M. (2015) Urinary Tract Infections in Patients with Type 2 Diabetes Mellitus: Review of Prevalence, Diagnosis, and Management. Diabetes, MetabolicSyndromeandObesity: TargetsandTherapy, 8, 129-136. https://doi.org/10.2147/dmso.s51792
[3]
Ahamadhullah, K., Kanakaraju, K., Rao, A.V.R. and Ilangovan, R. (2026) A Study of Clinical and Etiological Relation of Urinary Tract Infections in Patients with Type 2 Diabetes Mellitus. AnnalsofAfricanMedicine. https://doi.org/10.4103/aam.aam_749_25
[4]
(2022) Chinese Clinical Guidelines for the Prevention and Treatment of Type 2 Diabetes Mellitus in the Elderly (2022 Edition). ChineseJournalofDiabetes, 30, 2-51. (In Chinese)
[5]
Gupta, K., Hooton, T.M., Naber, K.G., Wullt, B., Colgan, R., Miller, L.G., et al. (2011) International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. ClinicalInfectiousDiseases, 52, e103-e120. https://doi.org/10.1093/cid/ciq257
[6]
Schuetz, A.N., Ferrell, A., Hindler, J.A., Humphries, R. and Bobenchik, A.M. (2025) Overview of Changes in the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: M100 32nd and 33rd Editions. JournalofClinicalMicrobiology, 63, e0162323. https://doi.org/10.1128/jcm.01623-23
[7]
Zhao, C. (2024) Professor Li Haisong’s Experience in Treating Diabetic Urinary Tract Infection and Study on Immune-Related Mechanism of Shuangdong Capsule. Master’s Thesis, Beijing University of Chinese Medicine. (In Chinese)
[8]
Li, H.Q. and Hong, T. (2021) Distribution of Pathogens and Analysis of Risk Factors in Type 2 Diabetes Mellitus Complicated with Perirenal Inflammation. Medical Science Journal of Central South China, 49, 310-313.
[9]
Foxman, B. (2014) Urinary Tract Infection Syndromes: Occurrence, Recurrence, Bacteriology, Risk Factors, and Disease Burden. InfectiousDiseaseClinicsofNorthAmerica, 28, 1-13. https://doi.org/10.1016/j.idc.2013.09.003
[10]
Filev, R., Lyubomirova, M., Bogov, B., Kolevski, A., Pencheva, V., Kalinov, K., et al. (2025) Urinary Tract Infections Caused by Klebsiella pneumoniae and Prolonged Treatment with Trimethoprim/sulfamethoxazole. Microorganisms, 13, Article No. 422. https://doi.org/10.3390/microorganisms13020422
[11]
Guo, D.L. and Zhang, J.J. (2023) Distribution and Drug Resistance of Pathogens in Type 2 Diabetes Patients with Urinary Tract Infections. GuideofChinaMedicine, 21, 35-38. (In Chinese)
[12]
Akgun, Z., Can, G.D. and Selver, O.B. (2025) Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Current Management and Changing Trends. IndianJournalofOphthalmology, 73, 1711-1722. https://doi.org/10.4103/ijo.ijo_1119_25
[13]
Klein, E.Y., Van Boeckel, T.P., Martinez, E.M., Pant, S., Gandra, S., Levin, S.A., et al. (2018) Global Increase and Geographic Convergence in Antibiotic Consumption between 2000 and 2015. ProceedingsoftheNationalAcademyofSciences, 115, E3463-E3470. https://doi.org/10.1073/pnas.1717295115
[14]
Tilahun, M., Kassa, Y., Gedefie, A. and Belete, M.A. (2021) Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review. InfectionandDrugResistance, 14, 4363-4374. https://doi.org/10.2147/idr.s337611
[15]
Tamma, P.D., Aitken, S.L., Bonomo, R.A., Mathers, A.J., van Duin, D. and Clancy, C.J. (2023) Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. ClinicalInfectiousDiseases, 77, S217-S235. https://doi.org/10.1093/cid/ciad428
[16]
Jafar, N., Edriss, H. and Nugent, K. (2016) The Effect of Short-Term Hyperglycemia on the Innate Immune System. TheAmericanJournaloftheMedicalSciences, 351, 201-211. https://doi.org/10.1016/j.amjms.2015.11.011
[17]
Nayak, M. and Vasantrao, P.C. (2019) A Study of Urinary Tract Infection in Post-Menopausal Women in Relation to Clinical and Microbiological Picture. JournalofEvidenceBasedMedicineandHealthcare, 6, 2968-2973. https://doi.org/10.18410/jebmh/2019/619
[18]
Al-Mehdar, A.A., Thawaba, Z.A., Al-Shami, H.Z., Al-Haifi, A.Y., Al-Worafi, Y. and Al-Shami, A.S. (2026) Bacterial Etiology and Antimicrobial Resistance Patterns of Urinary Tract Infections in Sana’a, Yemen. JournalofPharmaceuticalResearchInternational, 38, 34-51. https://doi.org/10.9734/jpri/2026/v38i27811
[19]
Alicic, R.Z., Rooney, M.T. and Tuttle, K.R. (2017) Diabetic Kidney Disease: Challenges, Progress, and Possibilities. ClinicalJournaloftheAmericanSocietyofNephrology, 12, 2032-2045. https://doi.org/10.2215/cjn.11491116
[20]
Yoosuf, B.T., KT, M.F., D P, S., Saini, A., Garg, P., Medenica, S., et al. (2025) Risk of Genitourinary Tract Infections with SGLT-2 Inhibitors in Type 2 Diabetes Mellitus: A Meta-Analysis of Randomised Controlled Trials and Disproportionality Analysis Using FAERS. Endocrine, 90, 439-452. https://doi.org/10.1007/s12020-025-04393-7
[21]
Takahashi, H., Komuro, H., Sato, K., Jingu, D., Yajima, T., Ubukata, S., et al. (2026) Incorporation of Sputum Real-Time RT-PCR into Routine Diagnostics Increases Case Detection of Respiratory Syncytial Virus Lower Respiratory Tract Infections in Older Adults. JournalofInfectionandChemotherapy, 32, Article ID: 102951. https://doi.org/10.1016/j.jiac.2026.102951
